Cargando…
Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
OBJECTIVE: Neuropathological studies in amyotrophic lateral sclerosis (ALS) have shown a dissemination in a regional sequence in four anatomically defined patterns. The aim of this retrospective study was to see whether longitudinal diffusion tensor imaging (DTI) data support the pathological findin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869447/ https://www.ncbi.nlm.nih.gov/pubmed/29101254 http://dx.doi.org/10.1136/jnnp-2017-316365 |
_version_ | 1783309289316679680 |
---|---|
author | Kassubek, Jan Müller, Hans-Peter Del Tredici, Kelly Lulé, Dorothée Gorges, Martin Braak, Heiko Ludolph, Albert C |
author_facet | Kassubek, Jan Müller, Hans-Peter Del Tredici, Kelly Lulé, Dorothée Gorges, Martin Braak, Heiko Ludolph, Albert C |
author_sort | Kassubek, Jan |
collection | PubMed |
description | OBJECTIVE: Neuropathological studies in amyotrophic lateral sclerosis (ALS) have shown a dissemination in a regional sequence in four anatomically defined patterns. The aim of this retrospective study was to see whether longitudinal diffusion tensor imaging (DTI) data support the pathological findings. METHODS: The application of DTI analysis to fibre structures that are prone to be involved at each neuropathological pattern of ALS was performed in a monocentre sample of 67 patients with ALS and 31 controls that obtained at least one follow-up scan after a median of 6 months. RESULTS: At the group level, longitudinal ALS data showed significant differences for the stage-related tract systems. At the individual level, 27% of the longitudinally scanned patients with ALS showed an increase in ALS stage, while the remaining were stable or were at the highest ALS stage. Longitudinal fractional anisotropy changes in the respective tract systems correlated significantly with the slope of the revised ALS functional rating scale. INTERPRETATION: The DTI-based protocol was able to image the disease patterns of ALS in vivo cross-sectionally and longitudinally, in support of DTI as a technical marker to image ALS stages. |
format | Online Article Text |
id | pubmed-5869447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-58694472018-03-28 Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker Kassubek, Jan Müller, Hans-Peter Del Tredici, Kelly Lulé, Dorothée Gorges, Martin Braak, Heiko Ludolph, Albert C J Neurol Neurosurg Psychiatry Neurodegeneration OBJECTIVE: Neuropathological studies in amyotrophic lateral sclerosis (ALS) have shown a dissemination in a regional sequence in four anatomically defined patterns. The aim of this retrospective study was to see whether longitudinal diffusion tensor imaging (DTI) data support the pathological findings. METHODS: The application of DTI analysis to fibre structures that are prone to be involved at each neuropathological pattern of ALS was performed in a monocentre sample of 67 patients with ALS and 31 controls that obtained at least one follow-up scan after a median of 6 months. RESULTS: At the group level, longitudinal ALS data showed significant differences for the stage-related tract systems. At the individual level, 27% of the longitudinally scanned patients with ALS showed an increase in ALS stage, while the remaining were stable or were at the highest ALS stage. Longitudinal fractional anisotropy changes in the respective tract systems correlated significantly with the slope of the revised ALS functional rating scale. INTERPRETATION: The DTI-based protocol was able to image the disease patterns of ALS in vivo cross-sectionally and longitudinally, in support of DTI as a technical marker to image ALS stages. BMJ Publishing Group 2018-04 2017-11-03 /pmc/articles/PMC5869447/ /pubmed/29101254 http://dx.doi.org/10.1136/jnnp-2017-316365 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Neurodegeneration Kassubek, Jan Müller, Hans-Peter Del Tredici, Kelly Lulé, Dorothée Gorges, Martin Braak, Heiko Ludolph, Albert C Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker |
title | Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker |
title_full | Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker |
title_fullStr | Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker |
title_full_unstemmed | Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker |
title_short | Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker |
title_sort | imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker |
topic | Neurodegeneration |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869447/ https://www.ncbi.nlm.nih.gov/pubmed/29101254 http://dx.doi.org/10.1136/jnnp-2017-316365 |
work_keys_str_mv | AT kassubekjan imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker AT mullerhanspeter imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker AT deltredicikelly imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker AT luledorothee imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker AT gorgesmartin imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker AT braakheiko imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker AT ludolphalbertc imagingthepathoanatomyofamyotrophiclateralsclerosisinvivotargetingapropagationbasedbiologicalmarker |